Advertisement

Interval Treatment of Congestive Heart Failure with Once-Daily Administration of 120 mg Isosorbide Dinitrate in Sustained-Release Form: No Evidence of Tolerance Development During Long-term Therapy

  • D. Hall
  • C. Stautner
  • F. Kraus
  • W. Rudolph

Zusammenfassung

Nitrate compounds, such as isosorbide dinitrate (ISDN), are useful agents with which acutely, elevated ventricular filling pressures can be lowered [3–5]. Since they are inexpensive, easy to use, and without serious side effects, their use for long-term treatment of congestive heart failure has gained wide acceptance without their actual efficacy having been conclusively proved. In studies performed on our service, similar to the response observed on continuous administration for treatment of angina pectoris, in patients with congestive heart failure, we found that the marked lowering of pulmonary artery pressure seen on the 1st day of treatment with 40 mg ISDN four times daily was already diminished after 3–4 days and completely attenuated by the 7th day of treatment [1, 2]. After a 1-day nitrate-free interval, on the 9th day of hemodynamic monitoring, renewed administration of the drug was met with full restitution of the effects, comparable to those seen after acute administration.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blasini R, Brügmann U, Mannes A, Froer KL, Hall D, Rudolph W (1980) Wirksamkeit von Isosorbiddinitrat in retardierter Form bei Langzeitbehandlung. Herz 5: 298–305PubMedGoogle Scholar
  2. 2.
    Blasini R, Froer KL, Blümel G, Rudolph W (1982) Wirkungsverlust von Isosorbiddinitrat bei Langzeitbehandlung der chronischen Herzinsuffizienz. Herz 7: 250–258PubMedGoogle Scholar
  3. 3.
    Franciosa J, Cohn J (1980) Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. Am J Cardiol 45: 648–654PubMedCrossRefGoogle Scholar
  4. 4.
    Franciosa J, Mikulic E, Cohn J, Jose E, Fabie A (1974) Hemodynamic effects of orally administered isosorbide dinitrate in patients with congestive heart failure. Circulation 50: 1020–1024PubMedGoogle Scholar
  5. 5.
    Gray R, Chatterjee K, Vyden J, Ganz W, Forrester J, Swan H (1975) Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure. Am Heart J 90: 346–352PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • D. Hall
    • 1
  • C. Stautner
  • F. Kraus
  • W. Rudolph
  1. 1.Deutsches HerzzentrumMünchen 11Germany

Personalised recommendations